NGM Biopharmaceuticals IPO Info
Company Name: NGM Biopharmaceuticals
Stock Symbol: NGM
Exchange: NASDAQ
Status: Priced
IPO Date: 4/4/2019
IPO Price:
16.00 (
15.56%)
Underwriters
Goldman Sachs, Citigroup and Cowen
Amount of Offering: N/A
Number of Shares Offered: 6.667 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
NGM is a clinical stage biopharmaceutical company focused on developing novel therapeutics based on scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic and ophthalmic diseases. The company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry, with multiple programs in clinical development.
News Headlines
